7 Review of guidance

7 Review of guidance

7.1 The guidance on this technology will be considered for review 3 years after publication of the guidance. The Guidance Executive will decide whether the technology should be reviewed based on information gathered by NICE, and in consultation with consultees and commentators. The review will to take into account experience of the patient access scheme.

Andrew Dillon
Chief Executive
September 2014

  • National Institute for Health and Care Excellence (NICE)